Inventor · disambiguated record
Anuraag Shrivastav
Also filed as: SHRIVASTAV ANURAAG
4 granted patents·4 pending applications·7 citations·filing 2006–2023
65Inventor score
Top patents by PatentIndex Score
8 records- 0185US11885808B2Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferaseCANADA INC·Filed 2022·Granted Jan 30, 2024·1 cites·8 claims
- 0271US7892758B2Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosisUNIV SASKATCHEWAN·Filed 2006·Granted Feb 22, 2011·4 cites·14 claims
- 0370US2024230656A1Predicting Prognosis and Treatment Response of Breast Cancer Patients Using Expression and Cellular Localization of N-MyristoyltransferaseONCODREX INC·Filed 2023·Application pending·0 cites
- 0469US11506663B2Methionine aminopeptidase overexpression in the peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancer screening, diagnosis and prognosisVASTCON·Filed 2015·Granted Nov 22, 2022·2 cites·1 claims
- 0567US2023285009A1N-myristoyltransferase 2 Overexpression in Peripheral Blood and Peripheral Blood Mononuclear Cells is a Marker for Colorectal CancerSHRIVASTAV ANURAAG·Filed 2023·Application pending·0 cites
- 0651US2019105025A1N-myristoyltransferase 2 Overexpression in Peripheral Blood and Peripheral Blood Mononuclear Cells is a Marker for Colorectal CancerSHRIVASTAV ANURAAG·Filed 2018·Application pending·0 cites
- 0740US12024748B2N-myristoyltransferase (NMT)1, NMT2 and methionine aminopeptidase 2 overexpression in peripheral blood and peripheral blood mononuclear cells is a marker for adenomatous polyps and early detection of colorectal cancerVASTCON·Filed 2017·Granted Jul 2, 2024·0 cites·5 claims
- 0839US2015337387A1N-myristoyltransferase 2 overexpression in peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancerSHRIVASTAV ANURAAG·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anuraag Shrivastav files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →